Adicet Bio Inc.

NASDAQ: ACET · Real-Time Price · USD
0.73
0.07 (11.45%)
At close: Aug 18, 2025, 2:56 PM

Adicet Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
56.49M 159.71M 257.66M 277.54M
Short-Term Investments
119.81M n/a n/a n/a
Long-Term Investments
n/a n/a n/a 150K
Other Long-Term Assets
3.33M 822K 1.21M 2.04M
Receivables
n/a n/a 435K 214K
Inventory
n/a n/a 2.57M 4.68M
Other Current Assets
474K 457K -2.19M -4.68M
Total Current Assets
180.14M 162.27M 261.04M 282.44M
Property-Plant & Equipment
36.75M 44.2M 48.98M 35M
Goodwill & Intangibles
n/a n/a 19.46M 19.46M
Total Long-Term Assets
40.08M 45.02M 69.65M 56.5M
Total Assets
220.22M 207.29M 330.69M 338.94M
Account Payables
4.83M 2.63M 4.4M 3.26M
Deferred Revenue
n/a n/a n/a 4.8M
Short-Term Debt
3.13M n/a n/a 1.57M
Other Current Liabilities
3.98M 6.93M 7.11M 2.45M
Total Current Liabilities
19.39M 19.29M 19.71M 16.32M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
116K 130K 114K 115K
Total Long-Term Liabilities
14.22M 17.83M 18.64M 19.49M
Total Liabilities
33.61M 37.12M 38.35M 35.81M
Total Debt
17.23M 20.92M 21.02M 20.94M
Common Stock
8K 4K 4K 4K
Retained Earnings
-497.89M -380.77M -238.11M -168.32M
Comprehensive Income
16K n/a n/a -338.94M
Shareholders Equity
186.61M 170.18M 292.34M 303.13M
Total Investments
119.81M n/a n/a 150K